The U.S. Food and Drug management simply approved bremelanotide as a unique treatment that is pharmaceutical pre-menopausal females with low libido. Marketed underneath the brand Vyleesi, the injectable medicine is used to deal with what happens to be referred to as hypoactive sexual desire disorder (HSDD). It’s the second libido-enhancing medicine on industry for ladies. (1st, Addyi, ended up being authorized in 2015 and it is a once-a-day capsule built to increase sexual interest. )
Data differ, but a lot more than a third of women report having low or libido that is limited ten percent have actually HSDD. Many — but, it is crucial to notice, not totally all — are searching for help increase their sexual drive.
We talked with Stacy Tessler Lindau, MD, MA, a teacher within the Department of Obstetrics and Gynecology and a specialist in intimate function whom operates the University of Chicago Medicine’s Program in Integrative Sexual Medicine and WomanLab.org, for more information on what this latest option that is pharmaceutical for women.